Regeneron reports narrower loss
-
- May
- 1
Regeneron Pharmaceuticals Inc. of Eastview lost $11.6 million, or 15 cents a share, during the first quarter, compared with a loss of $29.9 million, or 46 cents a share, a year earlier, the company reported this morning.
Revenues rose to $56.4 million from $15.8 million.
The company got approval to market its first product, Arcalyst, in February, and has several product candidates under development.
Regeneron shares were trading at $19.57, down 5 cents, this morning. The shares have dropped 29 percent the past year.
This entry was posted
on Thursday, May 1st, 2008 at 9:04 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
Advertisement
